HRT Financial’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Buy |
48,415
+26,997
| +126% | +$549K | ﹤0.01% | 1078 |
|
|
2025
Q1 | $388K | Buy |
+21,418
| New | +$388K | ﹤0.01% | 1436 |
|
|
2024
Q1 | – | Sell |
-13,243
| Closed | -$525K | – | 2272 |
|
|
2023
Q4 | $525K | Sell |
13,243
-8,362
| -39% | -$332K | ﹤0.01% | 1227 |
|
|
2023
Q3 | $594K | Buy |
+21,605
| New | +$594K | 0.01% | 1175 |
|
|
2023
Q1 | – | Sell |
-69,796
| Closed | -$3.11M | – | 2379 |
|
|
2022
Q4 | $3.11M | Buy |
+69,796
| New | +$3.11M | 0.04% | 394 |
|
|
2022
Q1 | – | Sell |
-20,487
| Closed | -$791K | – | 2902 |
|
|
2021
Q4 | $791K | Buy |
+20,487
| New | +$791K | ﹤0.01% | 1166 |
|
|
2021
Q2 | – | Sell |
-110,306
| Closed | -$2.27M | – | 2815 |
|
|
2021
Q1 | $2.27M | Buy |
110,306
+9,387
| +9% | +$193K | 0.02% | 467 |
|
|
2020
Q4 | $1.77M | Buy |
+100,919
| New | +$1.77M | 0.04% | 338 |
|
|
2019
Q1 | – | Sell |
-5,179
| Closed | -$15K | – | 520 |
|
|
2018
Q4 | $15K | Buy |
5,179
+3,953
| +322% | +$11.4K | ﹤0.01% | 539 |
|
|
2018
Q3 | $8K | Buy |
1,226
+428
| +54% | +$2.79K | ﹤0.01% | 348 |
|
|
2018
Q2 | $6K | Buy |
+798
| New | +$6K | ﹤0.01% | 244 |
|